The natural characteristics of antibodies, such as high binding affinity, specificity to a wide variety of targets, and good stability, make them ideal therapeutic candidates for many diseases. Monoclonal antibodies (mAbs), in particular, deliver promising therapeutic results in several different disease areas, such as autoimmunity, oncology, and chronic inflammation. Researchers’ abilities to improve the breadth of antibodies have been aided by innovative technologies for antibody discovery, for instance, through humanization of mouse antibodies and phage display. However, advanced antibody design techniques create the need for new screening methods so that lead candidates can be quickly and effectively identified as early in the development process as possible.

A solution to address these challenges is to use advanced screening methods that offer maximum insight through high-content data. Herein, we demonstrate an advanced antibody screening method that focuses on speed and insight by using a novel, pH-sensitive reagent for characterizing ABI via both advanced flow cytometry and live-cell imaging.

Learn more about Sartorius solutions for mAb Discovery & Development at www.sartorius.com/mAb-development